Ligand validation:6X0C

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6X0C_EDO_A_602	54%	93%	0.09	0.853	0.17	0.33	-	-	0	0	100%	1
6X0C_EDO_B_805	32%	90%	0.249	0.924	0.32	0.3	-	-	3	0	100%	1
6XE3_EDO_B_409	77%	99%	0.086	0.925	0.06	0.18	-	-	0	0	100%	1
7KWV_EDO_B_503	75%	100%	0.067	0.899	0.07	0.07	-	-	0	0	100%	1
6XIN_EDO_B_432	70%	96%	0.137	0.955	0.12	0.23	-	-	1	0	100%	0.66
7LKL_EDO_B_507	70%	95%	0.126	0.943	0.3	0.1	-	-	0	0	100%	1
7KBN_EDO_B_405	67%	84%	0.091	0.897	0.39	0.37	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.